| Literature DB >> 30113824 |
Jouha Min1, Hyungsoon Im1,2, Matthew Allen1, Phillip J McFarland1, Ismail Degani1,3, Hojeong Yu1, Erica Normandin4, Divya Pathania1, Jaymin M Patel5, Cesar M Castro1,6, Ralph Weissleder1,2,4, Hakho Lee1,2.
Abstract
The global burden of cancer, severe diagnostic bottlenecks in underserved regions, and underfunded health care systems are fueling the need for inexpensive, rapid, and treatment-informative diagnostics. On the basis of advances in computational optics and deep learning, we have developed a low-cost digital system, termed AIDA (artificial intelligence diffraction analysis), for breast cancer diagnosis of fine needle aspirates. Here, we show high accuracy (>90%) in (i) recognizing cells directly from diffraction patterns and (ii) classifying breast cancer types using deep-learning-based analysis of sample aspirates. The image algorithm is fast, enabling cellular analyses at high throughput (∼3 s per 1000 cells), and the unsupervised processing allows use by lower skill health care workers. AIDA can perform quantitative molecular profiling on individual cells, revealing intratumor molecular heterogeneity, and has the potential to improve cancer diagnosis and treatment. The system could be further developed for other cancers and thus find widespread use in global health.Entities:
Keywords: artificial intelligence; breast cancer; deep learning; diagnostics; global health
Mesh:
Year: 2018 PMID: 30113824 PMCID: PMC6519708 DOI: 10.1021/acsnano.8b03029
Source DB: PubMed Journal: ACS Nano ISSN: 1936-0851 Impact factor: 15.881